Expression and function of α2‐adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions
Open Access
- 8 August 2005
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 94 (6) , 1559-1569
- https://doi.org/10.1111/j.1471-4159.2005.03305.x
Abstract
The α2‐adrenoceptors are G‐protein‐coupled receptors that mediate many of the physiological effects of norepinephrine and epinephrine. Mammals have three subtypes of α2‐adrenoceptors, α2A, α2B and α2C. Zebrafish, a teleost fish used widely as a model organism, has five distinct α2‐adrenoceptor genes. The zebrafish has emerged as a powerful tool to study development and genetics, with many mutations causing diseases reminiscent of human diseases. Three of the zebrafish adra2 genes code for orthologues of the mammalian α2‐adrenoceptors, while two genes code for α2Da‐ and α2Db‐ adrenoceptors, representing a duplicated, fourth α2‐adrenoceptor subtype. The three different mammalian α2‐adrenoceptor subtypes have distinct expression patterns in different organs and tissues, and mediate different physiological functions. The zebrafish α2‐adrenergic system, with five different α2‐adrenoceptors, appears more complicated. In order to deduce the physiological functions of the zebrafish α2‐adrenoceptors, we localized the expression of the five different α2‐adrenoceptor subtypes using RT–PCR, mRNA in situ hybridization, and receptor autoradiography using the radiolabelled α2‐adrenoceptor antagonist [ethyl‐3H]RS‐79948–197. Localization of the α2A‐, α2B‐ and α2C‐adrenoceptors in zebrafish shows marked conservation when compared with mammals. The zebrafish α2A, α2Da, and α2Db each partially follow the distribution pattern of the mammalian α2A: a possible indication of subfunction partitioning between these subtypes. The α2‐adrenergic system is functional in zebrafish also in vivo, as demonstrated by marked locomotor inhibition, similarly to mammals, and lightening of skin colour induced by the specific α2‐adrenoceptor agonist, dexmedetomidine. Both effects were antagonized by the specific α2‐adrenoceptor antagonist atipamezole.Keywords
This publication has 44 references indexed in Scilit:
- Alpha‐2 adrenoceptor subtypes: are more better?British Journal of Pharmacology, 2005
- Clinical and pharmacological significance of α2-adrenoceptor polymorphisms in cardiovascular diseasesInternational Journal of Cardiology, 2004
- ?2-Adrenergic Receptor Subtypes ? Novel Functions Uncovered in Gene-Targeted Mouse ModelsBiology of the Cell, 2004
- Effects of common polymorphisms in the α1A-, α2B-, β1- and β2-adrenoreceptors on haemodynamic responses to adrenalineClinical Science, 2003
- Distribution of α2-Adrenergic Receptor Binding in the Developing Human Brain StemPediatric and Developmental Pathology, 2001
- Evaluation of the α2C-adrenoceptor as a neuropsychiatric drug target: Studies in transgenic mouse modelsLife Sciences, 2001
- Localization and trafficking of α2-adrenergic receptor subtypes in cells and tissuesPharmacology & Therapeutics, 1999
- Gene targeting — homing in on α2-adrenoceptor-subtype functionTrends in Pharmacological Sciences, 1997
- Distribution of ?2C-adrenergic receptor-like immunoreactivity in the rat central nervous systemJournal of Comparative Neurology, 1996
- The distribution and significance of CNS adrenoceptors examined with in situ hybridizationTrends in Pharmacological Sciences, 1996